| Name | Title | Contact Details |
|---|---|---|
Sharon Bosdet |
Head of Total Rewards and Human Resources Operations | Profile |
Eduardo Molina |
Vice President Marketing, Strategy and | Profile |
Ewa Tam |
Director of Marketing | Profile |
Jason Cole |
Chief Strategy and Financial Officer | Profile |
Katherine Breedis |
Interim Chief Financial Officer | Profile |
AlloVir, formerly ViraCyte, was founded in 2013 and is the leader in the development of novel cell therapies with a focus on restoring natural immunity against life-threatening virus-associated diseases in patients with severely weakened immune systems.
SOL (CSE:SOL) is an international cannabis company with a focus on legal U.S. states. Its strategic investments and partnerships across cultivation, distribution and retail complement the company`s R&D program with the University of Miami.
Oncothyreon is a Seattle, WA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Vesigen is developing groundbreaking therapeutic products directed to intracellular targets using a scalable and extracellular vesicle delivery technology.
Tasso is changing the way that care is delivered with simple, virtually painless, clinical-grade diagnostic testing that can be done from home.